Karine Belleville

851 total citations
23 papers, 697 citations indexed

About

Karine Belleville is a scholar working on Physiology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Karine Belleville has authored 23 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 12 papers in Cellular and Molecular Neuroscience and 8 papers in Molecular Biology. Recurrent topics in Karine Belleville's work include Pain Mechanisms and Treatments (9 papers), Neuropeptides and Animal Physiology (9 papers) and Receptor Mechanisms and Signaling (7 papers). Karine Belleville is often cited by papers focused on Pain Mechanisms and Treatments (9 papers), Neuropeptides and Animal Physiology (9 papers) and Receptor Mechanisms and Signaling (7 papers). Karine Belleville collaborates with scholars based in Canada, United States and France. Karine Belleville's co-authors include Philippe Sarret, Nicolas Beaudet, Jean‐Michel Longpré, Geneviève Roussy, Éric Marsault, Alexandre Murza, Christophe Noll, Farah Lizotte, Pedro Geraldes and Elliott Richelson and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Diabetes.

In The Last Decade

Karine Belleville

23 papers receiving 690 citations

Peers

Countries citing papers authored by Karine Belleville

Since Specialization

Citations

This map shows the geographic impact of Karine Belleville's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karine Belleville with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karine Belleville more than expected).

Fields of papers citing papers by Karine Belleville

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karine Belleville. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karine Belleville. The network helps show where Karine Belleville may publish in the future.

Co-authorship network of co-authors of Karine Belleville

This figure shows the co-authorship network connecting the top 25 collaborators of Karine Belleville. A scholar is included among the top collaborators of Karine Belleville based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karine Belleville. Karine Belleville is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A lipidated peptide derived from the C-terminal tail of the vasopressin 2 receptor shows promise as a new β-arrestin inhibitor 2025 ·Pharmacological Research ·Rebecca L. Brouillette, Christine E. Mona, (unknown), (unknown), (unknown), Firoza Z Lussier, Karine Belleville, Jean‐Michel Longpré, Michel Grandbois, Pierre‐Luc Boudreault, Élie Besserer‐Offroy, Philippe Sarret	1
2	Use of a Noninvasive Brain-Penetrating Peptide-Drug Conjugate Strategy to Improve the Delivery of Opioid Pain Relief Medications to the Brain 2020 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), (unknown), Karine Belleville, (unknown), (unknown), Anthony Régina, Michel Demeule, Philippe Sarret, Louis Gendron	14
3	Cell-penetrating pepducins targeting the neurotensin receptor type 1 relieve pain 2020 ·Pharmacological Research ·Rebecca L. Brouillette, Élie Besserer‐Offroy, Christine E. Mona, (unknown), Sandrine Lavenus, (unknown), Karine Belleville, Jean‐Michel Longpré, Éric Marsault, Michel Grandbois, Philippe Sarret	13
4	Combination of high-fat/high-fructose diet and low-dose streptozotocin to model long-term type-2 diabetes complications 2018 ·Scientific Reports ·David André Barrière, Christophe Noll, Geneviève Roussy, Farah Lizotte, (unknown), (unknown), Karine Belleville, Nicolas Beaudet, Jean‐Michel Longpré, André C. Carpentier, Pedro Geraldes, Philippe Sarret	126
5	A two-hit model of suicide-trait-related behaviors in the context of a schizophrenia-like phenotype: Distinct effects of lithium chloride and clozapine 2016 ·Physiology & Behavior ·Jessica Deslauriers, Karine Belleville, Nicolas Beaudet, Philippe Sarret, Sylvain Grignon	14
6	Descending nociceptive inhibition is modulated in a time-dependent manner in a double-hit model of chronic/tonic pain 2015 ·Neuroscience ·(unknown), Pascal Tétreault, (unknown), Karine Belleville, Jean‐Michel Longpré, Nicolas Beaudet, Philippe Goffaux, Philippe Sarret	14
7	Ghrelin Inhibition Restores Glucose Homeostasis in Hepatocyte Nuclear Factor-1α (MODY3)–Deficient Mice 2015 ·Diabetes ·François Brial, Carine Lussier, Karine Belleville, Philippe Sarret, François Boudreau	22
8	Stability and degradation patterns of chemically modified analogs of apelin‐13 in plasma and cerebrospinal fluid 2014 ·Biopolymers ·Alexandre Murza, Karine Belleville, Jean‐Michel Longpré, Philippe Sarret, Éric Marsault	53
9	Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive properties 2014 ·Journal of Clinical Investigation ·Michel Demeule, Nicolas Beaudet, Anthony Régina, Élie Besserer‐Offroy, Alexandre Murza, Pascal Tétreault, Karine Belleville, Christian Ché, (unknown), (unknown), Richard Béliveau, Jean‐Michel Longpré, Éric Marsault, Richard Leduc, Jean E. Lachowicz, Steven L. Gonias, Jean‐Paul Castaigne, Philippe Sarret	91
10	Spinal NTS2 receptor activation reverses signs of neuropathic pain 2013 ·The FASEB Journal ·Pascal Tétreault, Nicolas Beaudet, Amélie Perron, Karine Belleville, (unknown), Florine Cavelier, Jean Martínez, Thomas Stroh, Ashley M. Jacobi, Scott D. Rose, Mark A. Behlke, Philippe Sarret	41
11	Behavioral, Medical Imaging and Histopathological Features of a New Rat Model of Bone Cancer Pain 2010 ·PLoS ONE ·(unknown), (unknown), Karine Belleville, (unknown), (unknown), Luc Tremblay, Jean-François Beaudoin, Nicolas Beaudet, Roger Lecomte, Martin Lepage, Louis Gendron, Philippe Sarret	45
12	Altered morphine-induced analgesia in neurotensin type 1 receptor null mice 2010 ·Neuroscience ·Geneviève Roussy, Hélène Beaudry, (unknown), Karine Belleville, Nicolas Beaudet, Keiji Wada, Louis Gendron, Philippe Sarret	11
13	Involvement of NTS2 receptors in stress-induced analgesia 2009 ·Neuroscience ·(unknown), Geneviève Roussy, Karine Belleville, Hiroshi Maeno, Nicolas Beaudet, Keiji Wada, Philippe Sarret	51
14	Evidence for a Role of NTS2 Receptors in the Modulation of Tonic Pain Sensitivity 2009 ·Molecular Pain ·Geneviève Roussy, (unknown), (unknown), (unknown), Karine Belleville, Nicolas Beaudet, Jean Martínez, Elliott Richelson, Philippe Sarret	42
15	Spinal NTS1 receptors regulate nociceptive signaling in a rat formalin tonic pain model 2007 ·Journal of Neurochemistry ·Geneviève Roussy, (unknown), (unknown), Karine Belleville, Nicolas Beaudet, Elliott Richelson, Philippe Sarret	44
16	The First Preclinical Pharmacotoxicological Safety Assessment of CGS 35601, a Triple Vasopeptidase Inhibitor, in Chronically Instrumented, Conscious, and Unrestrained Spontaneously Hypertensive Rats 2006 ·Drug and Chemical Toxicology ·Philippe Daull, Raymond Lepage, Ouhida Benrezzak, (unknown), (unknown), Karine Belleville, A Blouin, Pierré Sirois, F. Nantel, A. Y. Jeng, Bruno Battistini	6
17	The hemodynamic and metabolic profiles of Zucker diabetic fatty rats treated with a single molecule triple vasopeptidase inhibitor, CGS 35601. 2006 ·PubMed ·Philippe Daull, A Blouin, (unknown), Simon Gadbois, Karine Belleville, (unknown), Nathalie Berthiaume, Pierré Sirois, F. Nantel, A. Y. Jeng, Bruno Battistini	6
18	Integrated in vivo pharmacology using an instrumented, unrestrained and conscious rat platform: Application to rat models of diabetes 2005 ·Journal of Pharmacological and Toxicological Methods ·F. Nantel, Philippe Daull, Nathalie Berthiaume, (unknown), A Blouin, (unknown), (unknown), Karine Belleville, Ouhida Benrezzak, Pierré Sirois, Bruno Battistini	3
19	Profiling biochemical and hemodynamic markers using chronically instrumented, conscious and unrestrained rats undergoing severe, acute controlled hemorrhagic hypovolemic shock as an integrated in-vivo model system to assess new blood substitutes 2005 ·Vascular Pharmacology ·Philippe Daull, A Blouin, (unknown), (unknown), Karine Belleville, Pierré Sirois, F. Nantel, T. M. S. Chang, Bruno Battistini	8
20	Triple Vasopeptidase Inhibition Normalizes Blood Pressure in Conscious, Unrestrained, and Spontaneously Hypertensive Rats 2005 ·American Journal of Hypertension ·Philippe Daull, Ouhida Benrezzak, (unknown), L.H. Pheng, A Blouin, (unknown), (unknown), Karine Belleville, Pierré Sirois, F. Nantel	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact